InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Carboat post# 243419

Monday, 11/23/2015 4:40:16 PM

Monday, November 23, 2015 4:40:16 PM

Post# of 346172

Correct. And the vast majority of investors have decided to pass on pphm. That is why ahareprice is $1.13



Carboat, what backing and support do you have that the pps is staying at this level?

I have plenty of reasons why it will increase, astronomically even.

Do you realize that DARPA is researching PS Targeting with Princeton ?? : )

Read slide #19-25 re: PS Targeting DARPA<>Princeton
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=118685922

https://www.princeton.edu/mae/people/faculty/miles/atmospheric-pressure-08-1/EnergyGundersen_apwip.pdf

Tick Tock... Tick Tock

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News